In addition to relying on evidence outlined in Farm Forward’s April 2024 report, the law firm behind the class action lawsuit ...
Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results